A discussion on the development of targeted therapies for the management of advanced cholangiocarcinoma, with consideration of multiple ongoing trials with notable outcomes.
EP. 1: Metastatic Cholangiocarcinoma: Targeted Therapy and NGS
EP. 2: FGFR Inhibition in Advanced CCA
EP. 3: FGFR Inhibitor MOA and Adverse Events
EP. 4: FGFR Versus Chemotherapy: DCR/DOR Efficacy
EP. 5: CCA Important Developments and Practical Advice
2 Clarke Drive Cranbury, NJ 08512